Paris - France, July 01, 2008 - Scient'x S.A., a privately-held company dedicated to spinal
implants, announced today the strengthening of its R&D department. Scient'x, continuing
its growth and expansion plans, has recently made two key additions to its Research and
Development Team. Scient’x has always had product and technology innovation at its core.
These senior managers have extensive spine and orthopedic experience and will reinforce the
existing talented development team. Their creativity and experience, combined with the
company’s investment in R&D will significantly bolster the product portfolio and accelerate
the technology development process. "This is in line with the strategy we have been
implementing to allow Scient'x to remain an innovation leader in the motion preservation
technology. We are excited to be expanding our development team and will continue to
add senior product managers" stated Michael D. Huggins, President and CEO. Scient'x and
Spinenetwork technologies are sold in over 50 countries. This infusion of R&D leadership
experience and technical expertise will have immediate worldwide benefits.
Mr. Robert BROSNAHAN, VP of Product Development
Mr. Robert Brosnahan will be in charge of product development worldwide. He will work with
the product development teams in both the US and France as the company executes a series of
strategic product development initiatives including new technology platforms, expanded
custom and prototype capacity as well as implementing a streamlined product development
Mr. Brosnahan brings with him over 26 years of experience in the medical device industry.
Most of his career was spent with Smith & Nephew where he held various positions such as
"Group Director, Product Development and Regulatory Affairs", "Group Director Product
Development Implants", and "VP Technology Licensing". He recently was working with
Enteroptyx Inc. as Senior VP R&D where he led a team of product development engineers. His
career has allowed him to build a broad industry knowledge and become a medical product
development engineering executive.
Mr. Brosnahan holds an MBA from University of Memphis, TN as well as a Master degree in
Biomedical engineering from the Clemson University. Over his career he has issued a number
of US patents as well as publications.
Mr. Emmanuel ZYLBER, R&D Director
Mr. Emmanuel Zylber will be responsible for the development and execution of the R&D
strategy, participating in the development of the company's product portfolio and project
pipeline. He will work to maintain and optimize the global product development process. He
will also serve as the company's front figure on technologies and trends on the market.
Mr. Zylber brings with him over nine years of R&D experience, of which, eight years was spent
in the spinal implant business. In his most recent position, Mr Zylber served as Principal Engineer
at Zimmer Spine where he was responsible for the development of dynamic stabilization
implants. He coordinated projects with designing surgeons and maintained the company’s
development process with crossfunctional teams including quality assurance and regulatory
affairs. He has extensive experience with the development of global product platforms and
design control procedures.
Mr. Zylber holds a Master degree in Mechanical Engineering with majors in Material Sciences
from the Ecole Nationale d'Ingénieurs de Tarbes.
Based in Paris, France, Scient’x, S.A. is the largest independent spinal implant company in
Europe. The Company designs, develops and distributes an extensive line of spine surgical
implants in over 50 countries around the world. Since 1988, Scient’x has been a pioneer in all
aspects of spinal instrumentation including the motion preservation segment of the spine
market. The Company was the first to introduce PEEK implants to spinal surgery as well as
posterior dynamic stabilization technology. Scient’x has now introduced a second generation
ceramic cervical disc that has achieved significant revenue traction and surgeon acceptance in
Europe. Scient’x is a privately held company.
For more information about the company, please visit www.scientx.com
Contact information: email@example.com